Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1G93A ALS Mouse Model via Upregulation of D-Amino Acid Oxidase
Authors:
- 19 December 2016
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 55 (1) , 682-695
Abstract
Self-complementary adeno-associated viral vector 9 (scAAV9) has been confirmed to be an efficient AAV serotype for gene transfer to the central nervous system (CNS). Neurotrophic factors have been considered to be therapeutic targets for amyotrophic lateral sclerosis (ALS). In the present study, we intramuscularly injected scAAV9 encoding human insulin-like growth factor 1 (hIGF1) into an hSOD1G93A ALS mouse model. We observed that scAAV9-hIGF1 significantly reduced the loss of motor neurons of the anterior horn in the lumbar spinal cord and delayed muscle atrophy in ALS mice. Importantly, IGF1 significantly delayed disease onset and prolonged the life span of ALS mice. In addition, scAAV9-hIGF1 protected motor neurons from apoptosis through upregulation of D-amino acid oxidase (DAO), which controls the level of D-serine. Moreover, to further verify these results, we used CRISPR-Cas9 system to target the central nervous system knockdown of IGF1. This experiment supported the continued investigation of neurotrophic factor gene therapies targeting the central nervous system as a potential treatment for ALS.Keywords
Funding Information
- the Natural Science Foundation of China (H0912-81171210)
- National Natural Science Foundation of China (C090301-30870882)
- Science and Technological department of Hebei Province (0647007D)
This publication has 35 references indexed in Scilit:
- The advent of AAV9 expands applications for brain and spinal cord gene deliveryExpert Opinion on Biological Therapy, 2012
- d -Amino acid oxidase controls motoneuron degeneration through d -serineProceedings of the National Academy of Sciences, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS MiceMolecular Therapy, 2010
- Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidaseProceedings of the National Academy of Sciences, 2010
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor NeuronsMolecular Therapy, 2009
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trialNeurology, 2008
- Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell ActivityMolecular Therapy, 2008
- D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Therapy, 2001